Select Publications

Conference Abstracts

Nivison-Smith I; Milliken S; Dodds A; Gottlieb D; Kwan J; Ma D; Shaw P; Tran S; Wilcox L; Szer J, 2018, 'Activity and Capacity Profile of Transplant Physicians and Centres in Australia and New Zealand', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, Vol. 24, pp. S272 - S273, presented at Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), UT, Salt Lake City, 21 February 2018 - 25 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425476000382&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martin P; Chen Z; Cheson BD; Robinson KS; Williams M; Rajguru SA; Friedberg JW; van der Jagt RH; LaCasce AS; Joyce R; Ganjoo KN; Bartlett NL; Lemieux B; VanderWalde A; Herst J; Szer J; Bar MH; Cabanillas F; Dodds AJ; Montgomery PG; Pressnail B; Ellis T; Smith MR; Leonard JP, 2017, 'Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma', in British Journal of Haematology, Vol. 178, pp. 250 - 256, http://dx.doi.org/10.1111/bjh.14667

Patton WN; Nivison-Smith I; Bardy P; Dodds A; Ma D; Shaw PJ; Kwan J; Wilcox L; Butler A; Carter JM; Blacklock H; Szer J, 2016, 'Graft Transit Time has no Effect on Outcome in Unrelated Donor Myeloablative Haematopoietic Cell Transplants (HCT) Performed in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry (ABMTRR) Study', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, HI, Honolulu, Vol. 22, pp. S345 - S346, presented at BMT Tandem Meetings, HI, Honolulu, 18 February 2016 - 22 February 2016, http://dx.doi.org/10.1016/j.bbmt.2015.11.836

Bryant A; Moore JJ; Dodds AJ; Milliken ST; Fay K; Ma DD, 2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', in Haematologica - the Hematology Journal, Ferrata Storti Foundation, Vol. 92, pp. 516 - 516


Back to profile page